121 related articles for article (PubMed ID: 36372610)
1. Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015.
Flechl B; Konrath L; Lütgendorf-Caucig C; Achtaewa M; Hug EB; Georg P
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1102-1114. PubMed ID: 36372610
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.
Dutz A; Agolli L; Bütof R; Valentini C; Baumann M; Lühr A; Löck S; Krause M
Radiother Oncol; 2020 Feb; 143():108-116. PubMed ID: 32044170
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
4. Proton therapy for low-grade gliomas: Results from a prospective trial.
Shih HA; Sherman JC; Nachtigall LB; Colvin MK; Fullerton BC; Daartz J; Winrich BK; Batchelor TT; Thornton LT; Mancuso SM; Saums MK; Oh KS; Curry WT; Loeffler JS; Yeap BY
Cancer; 2015 May; 121(10):1712-9. PubMed ID: 25585890
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types.
Youn SH; Ha B; Lee EH; Park B; Yang SE; Yu ES; Kim JY
Pediatr Blood Cancer; 2022 Mar; 69(3):e29430. PubMed ID: 34766721
[TBL] [Abstract][Full Text] [Related]
6. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
Zureick AH; Evans CL; Niemierko A; Grieco JA; Nichols AJ; Fullerton BC; Hess CB; Goebel CP; Gallotto SL; Weyman EA; Gaudet DE; Nartowicz JA; Ebb DH; Jones RM; MacDonald SM; Tarbell NJ; Yock TI; Pulsifer MB
Cancer; 2018 May; 124(10):2238-2245. PubMed ID: 29499085
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
Pulsifer MB; Duncanson H; Grieco J; Evans C; Tseretopoulos ID; MacDonald S; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):391-398. PubMed ID: 30108004
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
[TBL] [Abstract][Full Text] [Related]
10. Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors.
Welzel G; Fleckenstein K; Mai SK; Hermann B; Kraus-Tiefenbacher U; Wenz F
Strahlenther Onkol; 2008 Dec; 184(12):647-54. PubMed ID: 19107345
[TBL] [Abstract][Full Text] [Related]
11. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
Pulsifer MB; Sethi RV; Kuhlthau KA; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):400-7. PubMed ID: 26254679
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of proton radiation therapy in adults with low-grade glioma.
Sherman JC; Colvin MK; Mancuso SM; Batchelor TT; Oh KS; Loeffler JS; Yeap BY; Shih HA
J Neurooncol; 2016 Jan; 126(1):157-164. PubMed ID: 26498439
[TBL] [Abstract][Full Text] [Related]
13. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive and Psychological Functioning of Children with an Intracranial Germ Cell Tumor.
Park Y; Yu ES; Ha B; Park HJ; Kim JH; Kim JY
Cancer Res Treat; 2017 Oct; 49(4):960-969. PubMed ID: 28052648
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
Gondi V; Hermann BP; Mehta MP; Tomé WA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e487-93. PubMed ID: 22209148
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.
Tabrizi S; Yeap BY; Sherman JC; Nachtigall LB; Colvin MK; Dworkin M; Fullerton BC; Daartz J; Royce TJ; Oh KS; Batchelor TT; Curry WT; Loeffler JS; Shih HA
Radiother Oncol; 2019 Aug; 137():95-101. PubMed ID: 31082632
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
[TBL] [Abstract][Full Text] [Related]
19. The value of 4-month neurocognitive function as an endpoint in brain metastases trials.
Onodera S; Aoyama H; Tha KK; Hashimoto N; Toyomaki A; Terae S; Shirato H
J Neurooncol; 2014 Nov; 120(2):311-9. PubMed ID: 25037611
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
